CVA Family Office, LLC

Family Office

Position in OGN — Organon & Co.

CIK 1802084 DENVER, CO

Position in OGN

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$2,179

+$1,167 QoQ

Shares Held

161

-4.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#414

of 626 holders

Holding Since

Jun 2021

19 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CVA Family Office, LLC holds $13,101,368 across 15 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,076	$3,689,446
2	JNJ	Johnson & Johnson	9,737	$2,472,905
3	AMGN	Amgen Inc	4,049	$1,466,223
4	MRK	Merck & Co., Inc.	11,140	$1,431,490
5	ABBV	AbbVie Inc.	4,882	$1,228,506
6	NVS	Novartis AG	5,542	$868,542
7	BMY	Bristol Myers Squibb Co	9,306	$536,211
8	GSK	GSK plc	8,000	$419,360

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,179	161	-4.7%	Shares	Sole	2026-08-07
2026-03-31	$1,012	169	+238.0%	Shares	Sole	2026-04-29
2025-12-31	$358	50	0.0%	Shares	Sole	2026-01-12
2025-09-30	$534	50	0.0%	Shares	Sole	2025-10-30
2025-06-30	$484	50	0.0%	Shares	Sole	2025-07-31
2025-03-31	$744	50	+2.0%	Shares	Sole	2025-04-16
2024-12-31	$731	49	-21.0%	Shares	Sole	2025-01-07
2024-09-30	$1,186	62	+1.6%	Shares	Sole	2024-10-10
2024-06-30	$1,262	61	+1.7%	Shares	Sole	2024-07-10
2024-03-31	$1,128	60	+1.7%	Shares	Sole	2024-04-10
2023-12-31	$850	59	-96.2%	Shares	Sole	2024-01-16
2023-06-30	$32,026	1,539	+196.5%	Shares	Sole	2023-07-10
2023-03-31	$12,206	519	+50.9%	Shares	Sole	2023-04-27
2022-12-31	$9,607	344	-28.6%	Shares	Sole	2023-02-22
2022-09-30	$11,278	482	+0.2%	Shares	Sole	2022-11-22
2022-06-30	$16,233	481	0.0%	Shares	Sole	2022-07-11
2022-03-31	$16,801	481	0.0%	Shares	Sole	2022-04-22
2021-12-31	$14,646	481	-39.2%	Shares	Sole	2022-01-25
2021-06-30	$23,935	791	—	Shares	Sole	2021-07-13
No filing history on record for this holder in this stock.